Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Study reviews strategies to manage post-injury brain agitation (opens in a new tab)

news-medical.net · 2026-10-23

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 2 supported
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Two of five claims match the study. This overall rating is based only on the claims we could check. Three claims the study doesn't address.

  • 2 supported
  • 3 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The review scope is specifically agitation after moderate–severe TBI in the acute hospital setting.

    The story frames the topic more generally as agitation after TBI and does not preserve the profile’s moderate–severe TBI and acute-hospital-setting scope qualifiers.

    From Scoping review

  • The authors recommend holistic, individualized treatment considering medical, social, and psychiatric history, with supervised short-term roles for some medications.

    The story focuses on identified strategies and evidence limitations, but does not reflect this individualized/holistic-treatment recommendation from the paper profile.

    From Scoping review

4 things the story did carry across
  • The paper is a PRISMA-guided, PROSPERO-registered scoping review mapping pharmacological and non-pharmacological strategies for agitation after TBI, with 13 papers selected from 65 identified across PubMed, Embase/Ovid, and Cochrane searches.
  • Non-pharmacological findings emphasized orienting the patient and involving/supporting family during acute recovery.
  • Pharmacological findings reported olanzapine as helpful, with smaller or limited evidence for valproic acid and dextromethorphan plus quinidine.
  • The evidence base was limited, largely observational or review-based, with a paucity of randomized controlled trials and a need for larger primary research.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

1

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataSynthesize and map the past 10 years of evidence on pharmacological and non-pharmacological strategies to manage agitation in moderate–severe traumatic brain injury (TBI) in the acute hospital setting (scoping review).Scoping reviewExpand

In plain English

A PRISMA-guided scoping review (PROSPERO CRD 1295903) of literature from 01 Jan 2015 to 09 Mar 2026 searched PubMed, Embase (Ovid) and Cochrane to map pharmacological and non-pharmacological strategies for managing agitation after moderate–severe traumatic brain injury (TBI). From 65 records identified, 13 papers were selected and narratively synthesised by two reviewers. Non-pharmacological approaches emphasised patient orientation and family support during acute recovery. Pharmacological reports identified olanzapine as helpful, and smaller studies reported benefit with valproic acid (in a small male sample) and dextromethorphan plus quinidine. The included evidence base was largely observational studies and reviews with limited primary randomized trial data; authors highlight the need for larger, primary studies and individualized treatment considerations.

Key findings

  • Non-pharmacological strategies commonly emphasised orienting the patient and the supportive role of family during acute recovery to manage agitation after TBI.
  • Antipsychotic olanzapine was reported as helpful for managing agitation in moderate to severe TBI in included studies.
“A scoping review literature search was conducted using PRISMA guidelines.”
What this piece can’t prove
  • Most included studies were observational or reviews rather than randomized controlled trials (noted by authors).
  • Limited primary evidence and small sample sizes in some reported pharmacological studies (e.g., valproic acid study in a small male sample).
  • Abstract provides no quantitative effect estimates or detailed study-level methods/outcomes, restricting appraisal to narrative statements.
  • Scope limited to literature from 01 Jan 2015 to 09 Mar 2026 and to the databases searched (PubMed, Embase/Ovid, Cochrane) as reported.
Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 32 candidate papers

Candidate

Author response for "Design and Characterization of Ftaxilide-Conjugated VPA-Hydroxyapatite Nanohybrids for Anti-mycobacterial Applications"

2026 · Crossref

Candidate

Journal of Neurosurgical Anesthesiology 2025 Reviewer Acknowledgement

Journal of Neurosurgical Anesthesiology · 2026 · Crossref

And 26 more candidates considered.